IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB)
CUSIP: 45674E109
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 9,783,925
- Total 13F shares
- 1,777,567
- Share change
- +2,885
- Total reported value
- $7,803,000
- Price per share
- $4.39
- Number of holders
- 12
- Value change
- -$314,061
- Number of buys
- 7
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 45674E109?
CUSIP 45674E109 identifies INAB - IN8BIO, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45674E109:
Top shareholders of INAB - IN8BIO, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
8.2%
|
800,000
|
$5,520,000 | — | 30 Sep 2021 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
3.8%
|
375,000
|
$2,569,000 | — | 30 Sep 2021 | |
| BRC Group Holdings, Inc. |
13F
|
Company |
2.6%
|
257,378
|
$1,763,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
113,100
|
$775,000 | — | 30 Sep 2021 | |
| Voss Capital, LP |
13F
|
Company |
0.83%
|
80,727
|
$555,000 | — | 30 Sep 2021 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.65%
|
63,287
|
$434,000 | — | 30 Sep 2021 | |
| Rock Creek Group, LP |
13F
|
Company |
0.43%
|
42,279
|
$292,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
25,340
|
$175,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.1%
|
9,311
|
$64,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
3,435
|
$24,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
2,899
|
$20,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Sep 2021 |
Institutional Holders of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) as of Q4 2021
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.